Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Walter Stummer

13PUBLICATIONS
29CO-AUTHORS
Cellular nervous systemExercise physiologyBiogeography and phylogeographyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

Sort by Publication Date:
|May 14, 2026
Apoptosis and Glial Marker Profiles in Hippocampus and Amygdala of Medically Intractable Temporal Lobe Epilepsy.

|Jul 29, 2025
Enhancing cardiorespiratory fitness and quality of life in high-grade glioma through an intensive exercise intervention during chemotherapy: Proof of concept.

Johanna Jost-Engl, Ralf Ketter, Ralf Brandt

|May 12, 2025
Blood group O attributes to prolonged progression-free survival, overall survival, and 5-year survival in isocitrate dehydrogenase-wildtype glioblastoma patients with MGMT promoter methylation.

Rainer Wiewrodt, Maren Kloss, Johanna Jost-Engl

|Apr 23, 2025
Synthetic O-(2-<sup>18</sup>F-fluoroethyl)-l-tyrosine-positron emission tomography generation and hotspot prediction via preoperative MRI fusion of gliomas lacking radiographic high-grade characteristics.

Eric Suero Molina, Mehnaz Tabassum, Ghasem Azemi

|Oct 01, 2024
Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with lomustine/temozolomide.

Thomas Zeyen, Laura Böhm, Daniel Paech

|Apr 02, 2024
Beyond fluorescence-guided resection: 5-ALA-based glioblastoma therapies.

Walter Stummer, Michael Müther, Dorothee Spille

Pageof 3

Frequent Collaborators

3 joint publications

Dorothee Wiewrodt

2 joint publications

Johanna Jost-Engl

1 joint publications

Daniel A Orringer

1 joint publications

Stephanie Schipmann

1 joint publications

Peter Hau

1 joint publications

Alice Ryba

1 joint publications

Manfred Westphal

1 joint publications

Ulrich Schüller

1 joint publications

Malte Mohme

1 joint publications

Fabian M Troschel

Frequent Collaborators

3 joint publications

Dorothee Wiewrodt

2 joint publications

Johanna Jost-Engl

1 joint publications

Daniel A Orringer

1 joint publications

Stephanie Schipmann